Let G be a Poisson–Lie group equipped with a left invariant contravariant pseudo-Riemannian metric. There are many ways to lift the Poisson structure on G to the tangent bundle TG of G. In this paper, we induce a left invariant contravariant pseudo-Riemannian metric on the tangent bundle TG, and we express in different cases the contravariant Levi-Civita connection and curvature of TG in terms of the contravariant Levi-Civita connection and the curvature of G. We prove that the space of differential forms Ω*(G) on G is a differential graded Poisson algebra if, and only if, Ω*(TG) is a differential graded Poisson algebra. Moreover, we show that G is a pseudo-Riemannian Poisson–Lie group if, and only if, the Sanchez de Alvarez tangent Poisson–Lie group TG is also a pseudo-Riemannian Poisson–Lie group. Finally, some examples of pseudo-Riemannian tangent Poisson–Lie groups are given.
This article generalizes some geometric structures on warped product manifolds equipped with a Poisson structure to doubly warped products of pseudo-Riemannian manifolds equipped with a doubly warped Poisson structure. First, we introduce the notion of Poisson doubly warped product manifold (fB×bF,Π=μvΠBh+νhΠFv,g) and express the Levi-Civita contravariant connection, curvature and metacurvature of (fB×bF,Π,g) in terms of Levi-Civita connections, curvatures and metacurvatures of components (B,ΠB,gB) and (F,ΠF,gF). We also study compatibility conditions related to the Poisson structure Π and the contravariant metric g on fB×bF, so that the compatibility conditions on (B,ΠB,gB) and (F,ΠF,gF) remain consistent in the Poisson doubly warped product manifold (fB×bF,Π,g).
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.